http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022140917-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0886ec31ebb266f07c28875e8ff43a92 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 |
| filingDate | 2021-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cbbbad36558dce59479cec6ecbdf11b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05e33077da4da121971da6e0b06d2d80 |
| publicationDate | 2022-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2022140917-A |
| titleOfInvention | Ionic liquids, solvents, preparations and transdermal absorbers |
| abstract | An object of the present invention is to provide a transdermal absorber capable of improving the permeability of nucleic acids into the skin. The ionic liquid contains a cation obtained by ionizing the amino group of β-alanine ethyl ester and an anion represented by the general formula R -- COO.sub.2--. In the general formula, R represents a substituted or unsubstituted alkyl group or a substituted or unsubstituted alkenyl group, and at least one of the ethylene groups constituting the alkenyl group may be replaced with a vinylene group. [Selection drawing] Fig. 1 |
| priorityDate | 2021-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 169.